Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine

NCT06997562 is registered in ClinicalTrials.gov with New Valley University as lead sponsor.

NCT NCT06997562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06997562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine
Lead sponsor
New Valley University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
May 3, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

episodic migraine, greater occipital nerve block, sphenopalatine ganglion block